Anticancerdrugs

LAPAHOPE 250MG Description Lapahope 250mg tablet belongs to class of anti-neoplastic drugs which prevents the development and spreading of cancer cells all over the body. Lapahope is indicated for metastatic breast cancer and spreading after using of other chemotherapy drugs. Product Details Trade name :Lapahope  Active component : Lapatinib   Strength :250 mg  Manufactured by :Natco Pharma  Packing: 150 Tablets Mechanism Of Action Lapahope is a type of classification called kinase inhibitor and act by intracellular tyrosine kinase.  Lapahope prohibits ErbB-forced tumor cell growth in vitro and in various animal models. When combination 5-fluracil with Lapahope created an additive effect in the 4 tumor cell lines tested. Development inhibits the Lapahope tablet effect were examined in trastuzumab-conditioned cell lines.  Lapahope provide selective action against breast cancer cell lines selected for long-term growth in trastuzumab-containing intra

HERDUO 250MG Description Herduo 250mg tablet belongs to class of anti-neoplastic drugs which prevents the development and spreading of cancer cells all over the body. Herduo is indicated for metastatic breast cancer and spreading after using of other chemotherapy drugs. Product Details Trade name :Herduo  Active component : Lapatinib   Strength :250 mg  Manufactured by :Natco Pharma  Packing: 150 Tablets Mechanism Of Action Herduo is a type of classification called kinase inhibitor and act by intracellular tyrosine kinase.  Herduo prohibits ErbB-forced tumor cell growth in vitro and in various animal models. When combination 5-fluracil with Herduo created an additive effect in the 4 tumor cell lines tested. Development inhibits the Herduo tablet effect were examined in trastuzumab-conditioned cell lines.  Herduo provide selective action against breast cancer cell lines selected for long-term growth in trastuzumab-containing intracellularly. Horm

CRIZALK 250MG DESCRIPTION Crizalk 250mg capsule belongs to type of tyrosine kinase inhibitor. Kinases are enzymes which are contain in many functions, including cell development and reproduction. Crizalk 250mg prohibit the anaplastic lymphoma kinase (ALK) and the c-MET/hepatocyte growth factor receptor. This activity depresses certain pathways in the cell, which can prevent the growth of tumor cells. PRODUCT DETAILS Trade name                             Crizalk  Active component                  Crizotinib  Strength                                  250mg  Manufactured by                    Pfizer Ltd  Form                                      Capsules  Packing                                  60 tablets MECHANISM OF ACTION More specifically, crizotinibprevents anaplastic lymphoma kinase (ALK), hepatocyte growth factor receptor (HGFR, c-MET), and Recepteurd'OrigineNantais (RON).  Malformationin the ALK gene result by mutations or a

CRIZALK 200MG DESCRIPTION Crizalk 200mg capsule belongs to type of tyrosine kinase inhibitor. Kinases are enzymes which are contain in many functions, including cell development and reproduction. Crizalk 200mg prohibit the anaplastic lymphoma kinase (ALK) and the c-MET/hepatocyte growth factor receptor. This activitydepresses certain pathways in the cell, which can prevent the growth of tumor cells. PRODUCT DETAILS Trade name                  Crizalk  Active component        Crizotinib   Strength                       200mg  Manufactured by         Pfizer Ltd  Form                            Capsules  Packing                        60 tablets MECHANISM OF ACTION More specifically, crizotinibprevents anaplastic lymphoma kinase (ALK), hepatocyte growth factor receptor (HGFR, c-MET), and Recepteurd'OrigineNantais (RON).  Malformationin the ALK gene result by mutations or alteration may causes expression of oncogenic fusion proteins. C

GLENZA 40MG Glenza 40mg tablet is a non steroidal anti-androgen drug; by inhibiting the androgen synthesis and expels anti-neoplastic activity against prostate tumor. Glenza 40mg is an oral tablet form, which is endorsed by FDA. Enzalutamide is related with a reducing rate of serum enzyme increased during treatment, be that as it may, have not been connected to instances of clinically clear liver damage with jaundice. Product Details Trade name :Glenza  Active component : Enzalutamide  Strength :40MG  Manufactured by :Glenmark Pharmaceuticals Ltd  Pack :28 capsules Glenza 40mg tablet Mechanism of action Androgen is a male hormone; testosterone is a one of the hormone secreted from androgen which is responsible for growth of the tumor cells present in the prostate glands. Glenza 40 mg tablets are comprises of Enzalutamide which acts by inhibiting the binding of androgen into androgen receptor site. This inhibition leads to interfere with signal tr

AZEL 40MG Azel 40mg tablets are containing an active substance known as Enzalutamide, which has anti-tumor activity by exhibiting androgen receptor inhibitory activity. Azel 40mg is a non steroidal anti-androgen drug; by inhibiting the androgen synthesis and expels anti-neoplastic activity against prostate tumor. Azel 40mg is an oral tablet form, which is endorsed by FDA. Enzalutamide is related with a reducing rate of serum enzyme increased during treatment, be that as it may, have not been connected to instances of clinically clear liver damage with jaundice. Product Details Brand name : Azel  Active substance : Enzalutamide  Strength : 40MG  Manufactured by : Dr.Reddys Laboratories  Pack : 28 capsules Azel 40mg tablet Mechanism of action Androgen is a male hormone; testosterone is a one of the hormone secreted from androgen which is responsible for growth of the tumor cells present in the prostate glands. Azel 40 mg tablets are comprises of En

Bdenza 40mg Bdenza 40mg tablets are containing an active substance known as Enzalutamide, which has anti-tumor activity by exhibiting androgen receptor inhibitory activity. Bdenza 40mg is a non steroidal anti-androgen drug; by inhibiting the androgen synthesis and expels anti-neoplastic activity against prostate tumor. Bdenza 40mg is an oral tablet form, which is endorsed by FDA. Enzalutamide is related with a reducing rate of serum enzyme increased during treatment, be that as it may, have not been connected to instances of clinically clear liver damage with jaundice. Bdenza 40mg tablet Enzalutamide Mechanism of action Androgen is a male hormone; testosterone is a one of the hormone secreted from androgen which is responsible for growth of the tumor cells present in the prostate glands. Bdenza 40 mg tablets are comprises of Enzalutamide which acts by inhibiting the binding of androgen into androgen receptor site. This inhibition leads to interfere with signal tran

XTANDI 40MG Xtandi 40mg is a non steroidal anti-androgen drug; by inhibiting the androgen synthesis and expels anti-neoplastic activity against prostate tumor. Xtandi 40mg is an oral tablet form, which is endorsed by FDA. Enzalutamide is related with a reducing rate of serum enzyme increased during treatment, be that as it may, have not been connected to instances of clinically clear liver damage with jaundice. Xtandi 40mg Tablet Enzalutamide Mechanism of action Androgen is a male hormone; testosterone is a one of the hormone secreted from androgen which is responsible for growth of the tumor cells present in the prostate glands. Xtandi 40 mg tablets are comprises of Enzalutamide which acts by inhibiting the binding of androgen into androgen receptor site. This inhibition leads to interfere with signal transduction of receptors and causes growth retardation. The active metabolite of Enzalutamide is N-desmethyl Enzalutamide which is similar to parent form. Xtandi exh

Soranib (Sorafenib) 200mg Tablet Soranib is sold under the trade name of sorafenib sorafenib is belongs to the group of tyrosine kinase inhibitor, or angiogenesis inhibitor. Soranib is a targeted treatment which is used only under the knowledge of medical oncologist Soranib 200mg tablets may prohibits the cell growth Soranib is a prescription drug. Soranib 200mg PRODUCT DETAILS Brand Name                  Soranib  Composition                  Sorafenib Tosylate   Strength                        200mg  Manufactured by          Natco Pharma Ltd  Pack                              Pack of 120 Tablets Sorafenib Uses Soranib is a chemotherapeutic drug used to treat hepatocellular carcinoma, renal cell carcinoma, differentiated thyroid cancer(liver,kidney,thyroid) Mechanism Of Action Soranib inhibits the cell surface and intracellular kinase to reduces the growth of tumor cells. Soranib is a protein tyrosine kinase is a type of biological t

Sorafenat (Sorafenib) 200mg Tablet Sorafenat is sold under the trade name of sorafenib. Sorafenib is belongs to the group of tyrosine kinase inhibitor, or angiogenesis inhibitor. Sorafenat is a targeted treatment which is used only under the knowledge of medical oncologist Sorafenat tablets may prohibits the cell growth Sorafenat is a prescription drug. PRODUCT DETAILS Brand Name               Sorafenat  Composition              Sorafenib Tosylate  Strength                     200mg  Manufactured by       Natco Pharma Ltd  Pack                           Pack of 120 Tablets Sorafenat 200mg Uses Sorafenat 200mg tablet is a chemotherapeutic drug used to treat hepatocellular carcinoma, renal cell carcinoma, differentiated thyroid cancer(liver,kidney,thyroid) Mechanism Of Action Sorafenat inhibits the cell surface and intracellular kinase to reduces the growth of tumor cells. Sorafenat is a protein tyrosine kinase is a type of biol

LANIB 250MG Lanib belongs to class of anti-neoplastic drugs which prevents the development and spreading of cancer cells all over the body. Lanib is indicated for metastatic breast cancer and spreading after using of other chemotherapy drugs. Lanib is used with combination of capecitabine for the treatment of advanced breast cancer after the failure of other cancer medicine. Lanib is also used with letrozole combination to treat postmenopausal women with hormone receptor positive metastatic breast cancer. PRODUCT DETAILS: Trade name                      Lanib  Active component            Lapatinib Strength                           250 mg  Manufactured by             Novartis  Packing                           120 Tablets Mechanism Of Action Lanib is a type of classification called kinase inhibitor and act by intracellular tyrosine kinase. Lanib prohibits ErbB-forced tumor cell growth in vitro and in various animal models. When combination 5-flu

Erlocip   150mg Erlocip 150mg tablet is used as continuance therapy, in patients with long lasting or metastasis non small cell lung carcinoma, whose disease has not get advance after four cycles with platinum based first line therapy. Erlocip is used in this condition only after the failure of one prior chemotherapy regimen. No clinical advantages occur while using Erlocip with platinum based compounds like carboplatin, gemcitabine or cisplatin. Product Details Trade name :Erlocip  Active component : Erlotinib  Strength :150 mg  Manufactured by :Cipla Ltd.  Dosage Form :Tablets  Pack :Pack of 30 Tablets Erlotinib mechanism of action Erlocip has pharmacological effects like anti-neoplastic activity, which exhibits its action by inhibiting the intracellular phosphorylation of tyrosine kinase related with (EGFR) epidermal growth factor receptor. This EGFR signaling pathway is present on the surface of the tumor cells, this EGFR signaling is a critical pat

                    ERLONAT - 150MG An  Erlonat  tablets comprising of active component known as  Erlotinib , which is considered as quinazoline derivative and anti-cancer agents that responses as a protein kinase prohibitors for EGFR related to tyrosine kinase. Erlotinib  is majorly used in the treatment of non-small cell lung cancer and pancreatic carcinoma and also involved to treat various cancers.  Erlotinib  is especially aimed the epidermal growth factor receptor tyrosine kinase. Cyclin dependent kinase are protein kinases, it should be characterised by the support of subunit as cyclin. Erlonat 150mg Erlonat  usage Erlona t tablets are used in the conditions like;   Non small cell lung cancer     Pancreatic cancer Dosage & administration In NSCLC:  The usual recommended dosage of  Erlonat  is 150mg should be administered as a single dose by taking in an empty stomach for at least one hour earlier or two hours after intake